Norfloxacin |
Noroxin |
Article: Norfloxacin
| Image:Norfloxacin.png | |
| Norfloxacin | |
| Systematic (IUPAC) name | |
| 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1H-quinoline-3-carboxylic acid | |
| Identifiers | |
| CAS number | 70458-96-7 |
| ATC code | J01MA06 S01AX12 |
| PubChem | 4539 |
| DrugBank | APRD00469 |
| Chemical data | |
| Formula | C16H18FN3O3 |
| Mol. weight | 319.331 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | 3-4 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | |
| Routes | ? |
Norfloxacin is an oral broad-spectrum quinolone antibacterial agent used in the treatment of urinary tract infections.
Action:
The mechanism of action of norfloxacin involves inhibition of the A subunit of bacterial DNA gyrase, an enzyme which is essential for DNA replication. [1]
Categories: Pharmacology stubs | Fluoroquinolone antibiotics
Resources
- Norfloxacin (Drug Digest)
- Noroxin (Drug Digest)

Not Signed In -

